Key clinical point: Clinical trials for cancer are underreporting safety and efficacy data for elderly patients.
Major finding: Roughly 40% of articles reporting efficacy data and 9% of articles reporting safety data stratified results by age.
Study details: A systematic review of 159 articles describing phase 3 trials of chemotherapy in cancer patients.
Disclosures: The investigators disclosed no conflicts of interest.
BrintzenhofeSzoc K et al. J Geriatr Oncol. 2020 Jan 10. pii: S1879-4068(19)30501-6.